Literature DB >> 16860122

N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction.

Iris Fried1, Benjamin Bar-Oz, Zeev Perles, Azaria J J T Rein, Zeev Zonis, Amiram Nir.   

Abstract

OBJECTIVES: To determine whether acute left ventricular dysfunction (LVD) causes significantly higher elevation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels than comparable chronic LVD. STUDY
DESIGN: Plasma levels of NT-proBNP were measured in 10 pediatric patients diagnosed with acute LVD, in 7 pediatric patients with stable chronic dilated cardiomyopathy (DCM) and comparable levels of echocardiographic dysfunction, and during 5 episodes of acute exacerbation in patients with heart failure. Levels were compared using Mann-Whitney and analysis of variance for rank tests.
RESULTS: Plasma levels of NT-proBNP were excessively elevated in patients with acute LVD in the first 24 to 48 hours of hospitalization (median level, 65,600 pg/mL), and were significantly higher than those in patients with chronic DCM (median level, 1125 pg/mL; P < .0001). NT-proBNP levels decreased in the subsequent days in 83% of patients with serial measurements. The NT-proBNP levels were lower In 5 episodes of acute exacerbation than in acute LVD (median level, 7185 pg/mL; P < .003).
CONCLUSIONS: Acute LVD is associated with elevated NT-proBNP level in children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860122     DOI: 10.1016/j.jpeds.2006.02.038

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Plasma B-type natriuretic peptides in children with cardiovascular diseases.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2010-10-07       Impact factor: 1.655

2.  Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.

Authors:  Shivanand Shankar Medar; Daphne T Hsu; H Michael Ushay; Jacqueline M Lamour; Hillel W Cohen; James S Killinger
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

Review 3.  Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

Authors:  Afif El-Khuffash; Eleanor J Molloy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

4.  NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.

Authors:  Amal Zidan; Laila M Sherief; Amera El-sheikh; Safaa H Saleh; Doaa A Shahbah; Naglaa M Kamal; Hanan S Sherbiny; Heba Ahmad
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

5.  Assessment of Myocardial Function and Injury by Echocardiography and Cardiac Biomarkers in African Children With Severe Plasmodium falciparum Malaria.

Authors:  Simon Kotlyar; Peter Olupot-Olupot; Julius Nteziyaremye; Samuel O Akech; Sophie Uyoga; Rita Muhindo; Christopher L Moore; Kathryn Maitland
Journal:  Pediatr Crit Care Med       Date:  2018-03       Impact factor: 3.624

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.